These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 1386556)
21. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution. Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346 [TBL] [Abstract][Full Text] [Related]
22. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland. Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366 [TBL] [Abstract][Full Text] [Related]
23. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice. McGrath CM; Prass WA; Maloney TM; Jones RF J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884 [TBL] [Abstract][Full Text] [Related]
24. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization. Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447 [TBL] [Abstract][Full Text] [Related]
25. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma. Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561 [TBL] [Abstract][Full Text] [Related]
26. Wingless, the Drosophila homolog of the proto-oncogene Wnt-1, can transform mouse mammary epithelial cells. Ramakrishna NR; Brown AM Dev Suppl; 1993; ():95-103. PubMed ID: 8049493 [TBL] [Abstract][Full Text] [Related]
27. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Krane IM; Leder P Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899 [TBL] [Abstract][Full Text] [Related]
28. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Gorska AE; Joseph H; Derynck R; Moses HL; Serra R Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389 [TBL] [Abstract][Full Text] [Related]
29. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Schroeder JA; Troyer KL; Lee DC Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Kirma N; Gill K; Mandava U; Tekmal RR Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746 [TBL] [Abstract][Full Text] [Related]
31. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system. Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557 [TBL] [Abstract][Full Text] [Related]
32. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects. Ingman WV; Robertson SA Biol Reprod; 2008 Oct; 79(4):711-7. PubMed ID: 18614704 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Szeto W; Jiang W; Tice DA; Rubinfeld B; Hollingshead PG; Fong SE; Dugger DL; Pham T; Yansura DG; Wong TA; Grimaldi JC; Corpuz RT; Singh JS; Frantz GD; Devaux B; Crowley CW; Schwall RH; Eberhard DA; Rastelli L; Polakis P; Pennica D Cancer Res; 2001 May; 61(10):4197-205. PubMed ID: 11358845 [TBL] [Abstract][Full Text] [Related]
34. The Gli2 transcription factor is required for normal mouse mammary gland development. Lewis MT; Ross S; Strickland PA; Sugnet CW; Jimenez E; Hui C; Daniel CW Dev Biol; 2001 Oct; 238(1):133-44. PubMed ID: 11783999 [TBL] [Abstract][Full Text] [Related]
35. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes. Sarkar NH Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419 [TBL] [Abstract][Full Text] [Related]
36. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Michaelson JS; Leder P Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497 [TBL] [Abstract][Full Text] [Related]
37. Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. Liang TJ; Reid AE; Xavier R; Cardiff RD; Wang TC J Clin Invest; 1996 Jun; 97(12):2872-7. PubMed ID: 8675700 [TBL] [Abstract][Full Text] [Related]
38. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461 [TBL] [Abstract][Full Text] [Related]
39. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
40. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis. Mixon M; Kittrell F; Medina D Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]